Clinical trial
Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor by a Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study
NCT02555982 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor by a Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 27, 2016
- Completion date
- September 1, 2022
- Enrollment
- 120 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
essential head tremor